
Zvoľte si etiketu
zobrazené priamo na liekovkeTesofensine
Cutting
- Odosielame z Nemecka
Objednávka
- DHL so sledovaním zásielky
- Diskrétne balenie
4.6 z 5 na Trustpilote73 hodnotení
Hľadané aj ako: Tesofensin
V skratke
Tesofensine v číslach
Kľúčové údaje z nášho lexikónu. Posuňte bod po krivke a uvidíte, koľko podľa výpočtu zostáva po jednej dávke.
Celé heslo v lexikóneHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~9 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
about9days
- Class
- Triple monoamine reuptake inhibitorDA/NE/5HT
- Use
- Oral1 capsule per day
- Sizes
- 500 mcg1 size in the shop
What studies show
All 2 sources in the lexiconTesofensine in obesity - 6-month phase 2 study (opens in a new tab)
Astrup et al., Lancet, 2008Tesofensine, energy metabolism and appetite: 2-week study in 32 overweight men (opens in a new tab)
Sjödin et al., Int J Obes, 2010
Hodnotenia
Čo hovoria zákazníci
Len skutočné objednávky, ktoré obsahovali Tesofensine.
Všetky hodnoteniaPre Tesofensine zatiaľ neexistuje laboratórna analýza. Hlasujte za toDajte si to otestovať sami, polovicu zaplatímeVšetky laboratórne analýzy
Znalosti
Všetko o Tesofensine
Podrobné informácie pripravujeme.
Is tesofensine approved?
No. ChEMBL lists tesofensine with phase 2 as the highest phase. ClinicalTrials.gov lists 13 trials, none in phase 3, as of 26 October 2026.
How much did weight fall in the phase 2 trial?
203 people with obesity received a calorie-reduced diet and one of three levels or placebo. After 24 weeks weight fell by 4.5, 9.2 and 10.6 percent, by 2.0 percent on placebo. The authors called for confirmation in phase 3.
Does it work through appetite or energy expenditure?
Mainly through appetite. In a trial with 32 men satiety and fullness rose and expected food intake fell. Energy expenditure over 24 hours stayed the same, only at night it was 4.6 percent higher. Fat oxidation rose by 18 g per day.
What happens to pulse and blood pressure?
In the phase 2 trial heart rate rose by 7.4 beats per minute at the middle level. The low and middle levels did not significantly raise blood pressure after 24 weeks. Later trials test the combination with the beta blocker metoprolol.
Which side effects occurred?
Most common were dry mouth, nausea, constipation, hard stools, diarrhoea and insomnia. The checked abstract gives no shares per group.
Why was it first tested in Parkinson's and Alzheimer's?
Tesofensine raises dopamine, noradrenaline and serotonin in the brain. Under the name NS2330 several phase 2 trials ran on Parkinson's and Alzheimer's, the three largest with 945 participants in total. After that development switched to obesity.
Súvisiace
Súvisiace produkty
Clenbuterol
Lieky · Dýchacie cesty Dýchacie cesty
2 veľkosti
Laboratórne testované
T3 (Liothyronine)
Lieky · Štítna žľaza Štítna žľaza
3 veľkosti
Laboratórne testované
T4 (Levothyroxin)
Lieky · Štítna žľaza Štítna žľaza
3 veľkosti
Laboratórne testované
Salbutamol
Lieky · Dýchacie cesty Dýchacie cesty
1 veľkosť
Laboratórne testované
Tesofensine